Patients could be denied treatments, says BIA
Samsung to take on patent thicket surrounding Humira.
Industry giants such as AstraZeneca and Novartis are on board.
Leela Barham examines the approach of the Institute for Clinical and Economic Review.
Lung research needs support as fifth of UK diagnosed with respiratory condition.
A look ahead to the UK market in 2017 through the eyes of pharma industry leaders
02/11/2016November 1, 2016
22/11/2016October 20, 2016
08/12/2016October 18, 2016
A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.